Medicare Will Start Paying for Weight Loss Drugs Soon – But There’s a Catch
For years, the law has been clear: Medicare does not pay for weight loss. If you wanted Wegovy or Zepbound to shed pounds rather than cure diabetes, you were on your own, facing a monthly bill of $1,000 or more.
That rule technically still exists, but a big exception is about to poke a hole in it.
Starting this summer, a new federal program—commonly called “TrumpRx” but officially known as the GLP-1 Payment Demonstration—will allow certain Medicare Part D plans to cover these drugs with a strict copay cap. If you play your cards right, a once-expensive drug could be down to just $50 a month in July.
But there is a catch. This is not an automatic release for everyone. It’s a “voluntary model,” which means you need to confirm your eligibility and pre-register with your doctor now to access rates when the window opens.
‘TrumpRx’ timeline outlined
The government program is actually divided into two categories, and knowing the difference prevents you from not showing up at the pharmacy early.
1. Bridge (Commencing July 2026): Because the full system takes time to set up, CMS introduced a temporary “bridge” demonstration in July. This is an important “loophole” right now. Allows Medicare beneficiaries in participating programs to receive GLP-1 capped drugs $50 a copyeven before the official model is fully in place.
2. BALANCE model (Beginning January 2027): The comprehensive plan, known as the BALANCE Model, is officially included in Medicare Part D plans as of Jan. 1, 2027. This is when the installation becomes a regular part of the program’s offerings rather than a special feature.
Why you might miss it
The “voluntary” part of this model is where people will be fired. Because this is a pilot program, not every insurance carrier is required to participate in the July bridge phase.
According to information released by CMS, participation is optional for Part D sponsors. If your particular plan determines that the administrative burden is not appropriate, they may not offer the $50 premiums until mandatory changes or widespread adoption in 2027.
How to lock your eligibility
You can’t just walk into CVS in July and claim a $50 discount. You need to lay the groundwork now.
1. Check your plan’s participation status: Call the customer service number on the back of your Medicare Part D or Medicare Advantage card. Don’t ask “do you cover Ozempic?”—the answer will likely be “no” based on the old rules. Ask specifically: “Does this plan participate in the CMS GLP-1 payment demonstration starting in July?” If your current provider doesn’t participate, you may need to check how Medicare drug plans are changing to find one for the next open enrollment.
2. Find a specific diagnosis code: Coverage under TrumpRx/BALANCE is often tied to “obesity with comorbidities.” Your doctor needs to document not only your BMI, but related conditions-such as high blood pressure, diabetes, or high cholesterol-that justify a prescription under the label of “complete health” of the model.
3. Check the portal: As part of the program, a new pricing portal (“TrumpRx”) is expected to be launched for direct purchase. Keep an eye on Medicare.gov updates this spring, as the site may offer cash discounts (~$350/month) even before your insurance copay kicks in.
An important point
We’ve spent years telling you that Medicare won’t save you from the high cost of weight loss drugs. In July, that advice changes.
The medicine is the same, but the way to pay for it changes. If you can navigate the paperwork for this new model, you could save over $11,000 a year. If you ignore it, you will continue to pay the full price.
